VERVE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.21 USD | -1.33% |
|
+0.39% | -62.63% |
| May. 31 | Verve Therapeutics Names Troy Lister Chief Scientific Officer | MT |
| May. 31 | Verve Therapeutics, Inc. Announces Chief Scientific Officer Changes | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | |
|---|---|---|---|---|
| Last | 5.29 $ | 5.34 $ | 5.28 $ | 5.21 $ |
| Volume | 1 114 539 | 1 197 721 | 960 241 | 709 969 |
| Change | +0.76% | +0.95% | -1.12% | -1.33% |
| Opening | 5.20 | 5.35 | 5.32 | 5.20 |
| High | 5.47 | 5.35 | 5.37 | 5.30 |
| Low | 5.14 | 5.15 | 5.20 | 5.10 |
Performance
| 1 day | -1.33% | ||
| 1 week | +0.39% | ||
| Current month | +0.39% | ||
| 1 month | -18.08% | ||
| 3 months | -65.17% | ||
| 6 months | -59.27% | ||
| Current year | -62.63% | ||
| 1 year | -69.69% |
Volumes
marketsDaily volume
709 969
Estimated daily volume
709 969
Avg. Volume 20 sessions
1 367 794
Daily volume ratio
0.52
Avg. Volume 20 sessions USD
7 126 206.74
Record volume 1
13 929 424
Record volume 2
10 026 941
Record volume 3
6 679 580
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Capitalization (USD)
437 460 218
Net sales (USD)
11 758 000
Number of employees
255
Sales / Employee (USD)
46 110
Free-Float
92.3 %
Free-Float capitalization (USD)
403 760 662
Average Daily Capital Traded
1.63%
Highs and lows
1 week
5.10
5.47
1 month
4.906.83
Current year
4.9019.34
1 year
4.9021.42
3 years
4.9078.00
5 years
4.9078.00
10 years
4.9078.00
Indicators
Moving average 5 days
5.27
Moving average 20 days
5.65
Moving average 50 days
6.88
Moving average 100 days
9.98
Price spread / (MMA5)
+1.23%
Price spread / (MMA20)
+8.37%
Price spread / (MMA50)
+32.04%
Price spread / (MMA100)
+91.51%
STIM
RSI 9 days
34.52
RSI 14 days
31.65
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.33% | +0.39% | -62.63% | -69.69% | 437M | ||
| -2.38% | +5.93% | +51.85% | +22.51% | 57.87B | ||
| -0.07% | +2.97% | +41.14% | -11.14% | 40.25B | ||
| -0.57% | +0.06% | -5.25% | +6.12% | 39.94B | ||
| +0.42% | +8.46% | -5.16% | +13.08% | 28.54B | ||
| -0.85% | -1.71% | +12.79% | +43.87% | 26.4B | ||
| +2.33% | +2.93% | -20.18% | -19.94% | 19.33B | ||
| -0.47% | +3.84% | +30.88% | +93.01% | 12.4B | ||
| -1.52% | +0.57% | +0.61% | -1.02% | 12.23B | ||
| -0.51% | -0.05% | +25.06% | +20.36% | 12.2B | ||
| -3.08% | +3.05% | -9.14% | +8.66% | 11.06B | ||
| -0.18% | +3.68% | +0.17% | -3.94% | 9.95B | ||
| +0.47% | +5.24% | +40.66% | +57.95% | 6.66B | ||
| -0.89% | 0.00% | +19.92% | -13.20% | 6.56B | ||
| -1.02% | -2.10% | +12.03% | +76.74% | 6.47B | ||
| +0.25% | +5.79% | +3.78% | -20.25% | 6.35B | ||
| Average | -0.59% | +2.29% | +8.53% | +12.69% | ||
| Weighted average by Cap. | -0.69% | +2.96% | +17.93% | +14.59% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
c7e3bf89d81238.LVmlivWncTJS3kplUIBNGoR8r3E3cOf_d088GBa11_Y.ZQHX35_mGF0LmAAhIfB_d8oR9iMFNZOdMyoPfn_9r9trEub4kOEaCjWcDw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 5.21 | 111,371 | 572,116 |
| 03:59:58 pm | 5.2 | 100 | 460,745 |
| 03:59:58 pm | 5.2 | 100 | 460,645 |
| 03:59:56 pm | 5.21 | 120 | 460,545 |
| 03:59:55 pm | 5.2 | 400 | 460,425 |
| 03:59:55 pm | 5.205 | 119 | 460,025 |
| 03:59:54 pm | 5.21 | 100 | 459,906 |
| 03:59:53 pm | 5.21 | 153 | 459,806 |
| 03:59:53 pm | 5.21 | 100 | 459,653 |
| 03:59:53 pm | 5.21 | 124 | 459,553 |
Monthly variations
Annual change
| 2024 | -62.63% | ||
| 2023 | -27.96% | ||
| 2022 | -47.52% | ||
| 2021 | +15.51% |
- Stock Market
- Equities
- VERV Stock
- Quotes Verve Therapeutics, Inc.
